Looking for vexas syndrome in adults with unexplained inflammation
Part of Genetic & congenital, Immune system & allergy clinical trials.
This study aims to find out how common VEXAS syndrome is and how it looks in people over 50 who have unexplained inflammation or blood issues. It helps doctors better recognize and diagnose this rare condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 50.
- You are currently in an internal medicine department that is part of a specific hospital network in Italy.
- You have inflammation or blood problems that doctors can't yet explain.
- Doctors have ruled out an active infection or cancer as the cause.
- You have enough medical records available for the study team to check your situation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a national registry for people with VEXAS syndrome to track the disease and collect blood samples for research. Joining helps doctors learn more about VEXAS so they can better diagnose and treat it in the future.
This study tests an investigational drug called arumakimig (MAS825) in people with VEXAS, a rare genetic condition that causes inflammation. The trial checks if the drug helps control symptoms and improve quality of life.
This study tests whether the drug momelotinib can safely reduce inflammation and improve symptoms in people with VEXAS syndrome, a rare genetic condition. Participants will keep taking their usual steroids and may receive momelotinib or a placebo to see if it helps control the disease.
This trial tests a new drug called pacritinib for people with VEXAS syndrome, a rare autoinflammatory condition. The goal is to see if pacritinib can help control symptoms like rashes, joint pain, and low blood counts.
This trial tests a new treatment for people with advanced blood cancers like leukemia or lymphoma that have come back or not improved. The goal is to see if the drug can help control the disease.
This study looks for genes linked to autoinflammatory diseases like VEXAS syndrome. You or your family member can join by mailing in a blood or saliva sample to help researchers better understand these conditions.
Hear when a new VEXAS Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.